SCHEMBL8934512

SCHEMBL8934512

O=c1oc2ccc3ccccc3c2cc1Cc1ccc(O)cc1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR55 Q9Y2T6 1/20 0.82
CNR2 P34972 1/20 0.59
KDM4E B2RXH2 8/20 0.52
ALDH1A1 P00352 7/20 0.52
GLA P06280 4/20 0.52
GAA P10253 4/20 0.52
HPGD P15428 2/20 0.52
MAOB P27338 1/20 0.51
LMNA P02545 1/20 0.51
NQO1 P15559 1/20 0.50
POLB P06746 1/20 0.50
MAPT P10636 2/20 0.49
TSHR P16473 1/20 0.49
HTT P42858 1/20 0.49
HSD17B10 Q99714 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA9 Q16790 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15398169 0.90 GPR55 (1.00) GPR55CNR2KDM4EALDH1A1GLA
SCHEMBL28920340 0.78 POLB (0.69) GPR55KDM4EALDH1A1GLAGAA
Anemarcoumarin A SCHEMBL774777 0.77 POLB (0.77) GPR55KDM4EALDH1A1GLAGAA
SCHEMBL9529062 0.74
SCHEMBL29709847 0.72 GPR55 (0.68) GPR55KDM4EALDH1A1HPGDMAOB
SCHEMBL19331106 0.72 GPR55 (0.68) GPR55KDM4EALDH1A1HPGDMAOB
SCHEMBL1648127 0.71 NQO1 (0.83) ALDH1A1LMNANQO1TSHR
SCHEMBL15082534 0.70 HSD17B3 (0.51) GPR55CNR2KDM4EALDH1A1GLA
SCHEMBL15084994 0.70 GPR55 (0.47) GPR55CNR2KDM4EALDH1A1GLA
SCHEMBL8963452 0.70 KEAP1 (0.60) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO claimed
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO disclosed